A to Z of VTE: Primary Care Management of Venous Thromboembolism

Create Account

Availability

On-Demand

4 Courses

Access expires on May 31, 2027

Cost

$0.00

Credit Offered

3.5 AMA PRA Category 1 Credits

3.5 AOA Category 1-A Credits

Basic Course CME Information

AMA Credit and Designation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American College of Osteopathic Family Physicians (ACOFP) and American College of Osteopathic Internists (ACOI). ACOFP is accredited by the ACCME to provide continuing medical education for physicians.

ACOFP designates this enduring activity series for a maximum of 3.5 AMA PRA Category 1 Credits™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.

AOA Credit and Designation Statement
ACOFP is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians.

ACOFP designates this enduring activity series for a maximum of 3.5 AOA Category 1-A Credits and will report continuing medical education (CME) credits commensurate with the physician’s participation in this program.

Statement of Need
The goal of this series is to explore the clinical presentation of venous thromboembolism (VTE), common misdiagnoses, key challenges across the continuum of VTE management, and how fragmented care systems and complex anticoagulation regimens impact patients’ understanding, confidence, and adherence in VTE management. The series also covers anticoagulation therapy, including medication and monitoring; lifestyle modifications and risk-factor management to prevent recurrence; and the importance of regular monitoring.

Learning Objectives
After participating in this activity, attendees will be able to:

Identify and describe the clinical presentation of VTE
Utilize diagnostic tools and techniques, such as imaging studies and blood tests, to accurately diagnose VTE
Identify and avoid common misdiagnoses associated with VTE
Apply diagnostic strategies to accurately differentiate VTE from other possible conditions
Identify the key challenges in VTE transitions of care
Apply best practices for effective communication and care coordination
Implement evidence-based strategies for patient education and adherence
Develop preparedness for emergency situations in VTE management
Identify common challenges patients face when navigating fragmented cares systems and complex anticoagulation regimens and apply empathetic communication strategies to address them
Describe the role of shared decision-making in VTE management and how patient perspectives influence understanding and adherence to clinical guidance
Identify key barriers to treatment adherence and follow-up in VTE care and integrate patient-centered approaches to improve care coordination and outcomes
Analyze and apply principles of anticoagulation therapy
Design lifestyle modifications and manage risk factors to reduce the likelihood of VTE recurrence
Establish and follow regular monitoring protocols to assess treatment efficacy and adjust therapies as needed
Recognize and address potential complications and recurrence
Assess and manage VTE recurrence in special patient populations with unique health conditions or higher risk
Create effective patient education strategies while providing ongoing support

End Date: October 31, 2025
Estimated Time to Complete the Course: 3.5 hours

Instructional Format
Enduring on-demand video recordings, reading, and assessments

Method of Participation
View the recordings. Read the lessons. Complete the assessments and the evaluation.

Disclosures

ACOFP is committed to providing learners with high-quality CME/CE activities that promote improvements in health care and not those of an ineligible company. In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. ACOFP requires that individuals in a position to control the content of an educational activity disclose all financial relationships with any ineligible company (those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients). Individuals in a position to control the content may include, but are not limited to, planning committee members, authors, faculty, speakers, reviewers, and activity staff.

ACOFP review all disclosed relationships to determine which are relevant and then work with the applicable contributors to mitigate the relevant financial relationships.

No relevant financial relationships were identified for any individual in control of content for this specific activity.

Disclaimer
ACOFP presents this information for educational purposes only. The content is provided solely by individuals who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. ACOFP and the supporter assume no liability for the information herein.

Commercial Support
The activity is supported by an independent educational grant from the Bristol Myers Squibb and Pfizer Alliance.